Clinical Trial Update: Evaluating the Performance of AI in Evaluating Breast MRI Performed With Dose Reduction [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing the performance of an artificial intelligence system in evaluating breast MRI with dose reduction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Breast Tumor
• Breast Cancer

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Breast Benign Tumor, Breast Malignant Tumor | Phase 1 | Status: COMPLETED